美国2016-2022年孕前糖尿病与妊娠期糖尿病趋势及与严重孕产妇并发症的关联
该回顾性研究基于美国2016-2022年住院样本中25,138,817例分娩住院数据,分析妊娠期糖尿病(GDM)、孕前1型和2型糖尿病及严重孕产妇并发症(SMM)的趋势与关联。结果显示GDM和孕前2型糖尿病患病率上升,SMM亦增加;调整社会人口学因素后,1型糖尿病与最高的非输血SMM风险相关(RR 4.94),其次为2型糖尿病(RR 2.58)和GDM(RR 1.12)。结论强调所有类型糖尿病均增加SMM风险,需加强心血管代谢管理和多学科综合照护。
要点
- GDM患病率从7.1升至9.5/100次分娩,孕前2型糖尿病从0.8升至1.1/100次分娩。
- 总体SMM从160.0升至220.3/万次分娩,非输血SMM从72.0升至93.0/万次分娩。
- 1型糖尿病非输血SMM风险最高(RR 4.94),其次2型(RR 2.58)和GDM(RR 1.12)。
核心结论
- 2016至2022年GDM和孕前2型糖尿病患病率上升,SMM同步增加。
- 孕前糖尿病尤其是1型糖尿病与更高的SMM风险相关。
- 所有妊娠期糖尿病类型均增加SMM风险,需重视心血管代谢风险管理及多学科照护。
研究设计与样本
- 回顾性研究,使用2016-2022年医疗成本与利用项目全国住院样本。
- 纳入12-55岁女性分娩住院,共25,138,817例。
- 采用改良泊松回归估计总体及非输血SMM的相对风险,调整社会人口学和临床特征。
主要发现
- GDM患病率从7.1升至9.5/100次分娩,孕前2型糖尿病从0.8升至1.1/100次分娩,孕前1型糖尿病稳定在0.3/100次分娩。
- 总体SMM从160.0升至220.3/万次分娩,非输血SMM从72.0升至93.0/万次分娩。
- 社会人口学调整模型中,相比无糖尿病女性,1型糖尿病非输血SMM的RR为4.94(95%CI 4.55-5.35),2型糖尿病为2.58(95%CI 2.43-2.74),GDM为1.12(95%CI 1.08-1.15)。
临床怎么用
- 对孕前1型和2型糖尿病患者应加强孕前及孕期心血管代谢风险管理。
- GDM患者虽SMM相对风险较低,但患病率上升,仍需规范管理。
- 建议对妊娠合并糖尿病患者提供多学科综合照护以降低SMM风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe trends in the prevalence of gestational diabetes mellitus (GDM), pregestational diabetes (type 1 and type 2), and severe maternal morbidity (SMM) in the U.S., and to examine associations between diabetes status and type with SMM. RESEARCH DESIGN AND METHODS: This retrospective study used 2016-2022 data from the Healthcare Cost and Utilization Project National Inpatient Sample. Delivery hospitalizations among women ages 12-55 years were identified. Modified Poisson regression models were used to estimate relative risks (RRs) for overall and nontransfusion SMM, adjusting for sociodemographic and clinical characteristics. RESULTS: Among 25,138,817 delivery hospitalizations, the prevalence of GDM increased from 7.1 to 9.5 per 100 deliveries, pregestational type 2 diabetes increased from 0.8 to 1.1 per 100 deliveries, and pregestational type 1 diabetes remained stable at 0.3 per 100 deliveries from 2016 to 2022. Overall SMM increased from 160.0 to 220.3 per 10,000 deliveries; nontransfusion SMM increased from 72.0 to 93.0 per 10,000 deliveries. In sociodemographic-adjusted models, compared with women without diabetes, type 1 diabetes was associated with the highest risk of nontransfusion SMM (RR 4.94; 95% CI 4.55-5.35), followed by type 2 diabetes (RR 2.58; 95% CI 2.43-2.74) and GDM (RR 1.12; 95% CI 1.08-1.15). CONCLUSIONS: From 2016 to 2022, GDM and pregestational type 2 diabetes rose in parallel with increasing SMM. While GDM was the most prevalent, pregestational diabetes, particularly type 1, was associated with a higher risk of SMM. The increased risk for SMM associated with all forms of diabetes in pregnancy highlights the importance of cardiometabolic risk management and the need for comprehensive, multidisciplinary care during pregnancy and delivery.
引用
- Fwu CW, Casagrande SS, Lawrence JM, et al. Trends in Pregestational Diabetes and Gestational Diabetes Mellitus and Associations With Severe Maternal Morbidity in U.S. Delivery Hospitalizations, 2016-2022. Diabetes Care. 2026. PMID: 42319764. doi:10.2337/dc26-0586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。